AUTOLUS THERAPEUTICS P

Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences

08 Dec 2022 16:02:48 By Nasdaq GlobeNewswire

Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis

08 Dec 2022 16:01:35 By Nasdaq GlobeNewswire

Autolus Therapeutics announces handover of first clean rooms of new Stevenage, UK, manufacturing facility

30 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Present Three Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022

03 Nov 2022 09:31:08 By Nasdaq GlobeNewswire

Autolus Therapeutics Reports Third Quarter 2022 Financial Results and Operational Progress

03 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

Autolus Therapeutics to Report Third Quarter 2022 Financial Results on November 3, 2022

21 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Moderna exercises option to license proprietary targeting technology from Autolus

12 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus’ Proprietary Safety Switch System

04 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Autolus Therapeutics Reports Second Quarter 2022 Financial Results and Operational Progress

04 Aug 2022 07:00:02 By Nasdaq GlobeNewswire

Correction - Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022

21 Jul 2022 07:54:01 By Nasdaq GlobeNewswire

Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022

21 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Participate in William Blair’s Biotech Focus Conference 2022, New York, July 12 – 13, 2022

06 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association Congress

10 Jun 2022 03:01:00 By Nasdaq GlobeNewswire

Autolus to hold Annual General Meeting (AGM) of Shareholders on Tuesday, June 28, 2022

31 May 2022 16:01:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Participate in the Jefferies Healthcare Conference, being held in New York from June 8 – 10, 2022

27 May 2022 07:45:51 By Nasdaq GlobeNewswire

Autolus Therapeutics to Present Four Clinical Data Updates at the European Hematology Association Congress

12 May 2022 10:51:46 By Nasdaq GlobeNewswire

Autolus Therapeutics Reports First Quarter 2022 Financial Results and Operational Progress

05 May 2022 07:00:01 By Nasdaq GlobeNewswire

Autolus Therapeutics to Present Three Novel Cell Programming Approaches at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting, May 16-19, 2022 

02 May 2022 16:31:00 By Nasdaq GlobeNewswire

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) designation to Autolus’ CAR T cell therapy, obe-cel, for the treatment of adult B-ALL

25 Apr 2022 07:01:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 5

25 Apr 2022 07:00:00 By Nasdaq GlobeNewswire